Gilead Sciences, Inc. (GILD)

S&P 500: 758.34
Change: 0.78%

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

Avatar kslanicky (68.32) Submitted: 3/12/08 10:16 AM : Start Price: $48.16 GILD Score: 29.51

Lock on AIDS market - nothing more needs to be said.

Featured Broker Partners